● Policy Support
The country's macroeconomic policy is the orientation of a project or even an industry
By the end of 2005, "National Medium and Long-term Scientific and Technological Development Plan" clearly pointed out that we should vigorously develop biotechnology;
In 2010, among the key projects under the 12th Five-Year Plan, regenerative medicine and tissue engineering were listed as one of the key projects in the biomedical category.
In 2011, the State Health Planning Commission made clear the regulatory policies in the field of stem cell research and development (including the Measures for the Management of Stem Cell Clinical Trial Research, the Measures for the Management of Stem Cell Clinical Trial Research Base, the Guidelines for Quality Control of Stem Cell Preparations and Preclinical Research)
The 2013 national "Thirteen Five" biotechnology prediction also shows the important position of stem cell-tissue engineering-regenerative medicine.
In 2016, the Ministry of Science and Technology issued the "Implementation Plan for Key National R & D Stem Cells and Translational Medicine Key Projects". In the same year, according to the requirements of the Measures for the Management of Stem Cell Clinical Research (Trial) (Guo Wei Ke Jiao Fa  No. 48) The Planning Commission and the General Administration of Food and Drug Administration promulgated the "Notice on Establishing a National Expert Committee on Clinical Research of Stem Cells"
In the past ten years, the projects of 973, 863, major new drug creation and the National Natural Science Foundation of China have all set the direction of stem cell-tissue engineering-regenerative medicine.
Former Premier Wen Jiabao highly praised stem cell research and development. "Stem cell research has promoted the development of regenerative medicine. This is another medical revolution after drug treatment and surgical treatment. We must strive to take a leading position in more areas of stem cell research & rdquo ;. Promote the development of stem cell science and technology as an important part of the "Outline of National Medium and Long-term Scientific and Technological Development Plan", which has been listed in the "Eleventh Five-year" National Key Science and Technology Project formulated by the Ministry of Planning and Science and Technology.
The development strategy of national regenerative medicine research clearly states: In 2020, important breakthroughs should be made in the key technologies of stem cell-tissue engineering products and their applications should be made clinically. Therefore, this kind of product provides a regenerative medicine alternative for all kinds of diseases that can not be cured clinically; provides new ideas for the research and development of new drugs and stem cell research; and also provides a new development direction for the medical cosmetology and cosmetics industry in the field of consumption.
It is foreseeable that for a long period of time, the development of the related industries of stem cell-tissue engineering regeneration and repair will be vigorously supported by the policy.
● Stem cells overall marketIndustry analysis
Tissues and organs of the damage or failure is a major human health problems facing our country due to trauma, disease caused by tissue, organ damage or dysfunction in patients with the first in the world, its treatment include: transplantation, surgical repair, artificial leave Body, mechanical devices and medication, however, these treatment regimens are still difficult to achieve the goal of tissue or organ repair. Stem cells, a new area of regenerative medicine that has been in the ascendant in recent years, are intended to provide new therapies for diseases treated by traditional therapies, through stem cell transplantation, differentiation and tissue regeneration, to promote wound repair and disease management in the body And hope, is expected to become the drug treatment, surgical treatment of the third disease treatment, promising.
The vast majority of stem cell products are still in the research stage. There are only a few stem cell products that are actually listed in the world. Now that all countries are aware of the huge potential market for stem cells and the necessity and importance of developing stem cell market, stem cell research and applications are listed as countries Focus on the development of the pillar industries, accelerating the market-oriented investment in stem cell products, so the rapid development of stem cell market has been evident. According to the analysis by UK Visiongain, the market value of stem cells in 2015 reached 150 billion U.S. dollars. If the relevant industries such as pharmaceuticals are taken into account, the global market will reach 400 billion U.S. dollars per year by 2020. In China, stem cell & regenerative medicine has also been strongly supported by the relevant state departments and included in the "National Key Basic Research and Development Program" ("973") project as well as the national "863" Science and Technology Development Plan "of the important content, was included in the national" Eleventh Five-Year "Ministry of Science and Technology formulated major national science and technology projects to promote and foster stem cells & regenerative medicine research and product development. Regenerative medicine will drive and promote the cross penetration and development of relevant high-tech fields and gradually develop into a high-tech industry with great potential in the 21st century, which will surely bring great social and economic benefits. In this situation, stem cells & regenerative medicine will definitely be the focus of the country's development. In 2015, the revenue of stem cell industry in China reached 30 billion with an annual growth rate of more than 100%. It is estimated that the potential demand for stem cell applications in 2025 will reach RMB100 billion / year.
In this huge market of stem cell industrialization, both the standards for clinical research, outsourcing of stem cell research and institutions related to stem cell and research services for regenerative medicine will all occupy a huge market share in this industrial chain.